Mechanisms of autoimmunity

Howie JB, Helyer BJ: The immunology and pathology of NZB mice. Adv Immunol 1968;9: 215–266. Wakeland EK, Foppoli JM, Benediet AA: Genetic dissection of lupus nephritis in murine models of SLE. J Clin Immunol 1997; 17:272–281. Vyse TJ, Kotzin BL: Genetic susceptibility to systemic lupus erythematosus. in Annual Review of Immunology Paul WE, Fathman CG, Glimcher LH, (eds.) Palo Alto, Annual Reviews, Inc., 1998, pp. 261–292. Boackle SA, Holers VM, Chen X, et al.: Cr2, a candidate gene in the murine Slelc lupus susceptibility locus, encodes a dysfunctional protein. Immunity 2001;15:775–785. Morel L, Blenman KR, Croker BP, et al: The major murine systemic lupus erythematosus susceptibility locus, Slel, is a cluster of functionally related genes. Proc Natl Acad Sci USA 2001;98:1787–1792. Rozzo SJ, Allard JD, choubey D, et al: Evidence for an Interferon-Inducible Gene, Ifi202, in the Susceptibility to Systemic Lupus. Immunity 2001;15:435–443. Ibouz-Zekri N, Vyse TJ, Rozzo SJ, et al: MHC-linked control of murine SLE. Curr Top Microbiol Immunol 1999;246:275–280. Cohen PL, Eisenberg RA: Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Ann Rev Immunol 1991;9:243–269. Eisenberg RA, Dixon FJ: Effect of castration on male-determined acceleration of autoimmune disease in BXSB mice. J Immunol 1980;125:1959–1961. Eisenberg RA, Izui S, McConahey PJ, et al: Male determined accelerated autoimmune disease in BXSB mice: transfer by bone marrow and spleen cells. J Immunol 1980;125:1032–1036. Chan OT, Madaio MP, Shlomchik MJ: The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 1999;169:107–121. Shlomchik MJ, Craft JE, Mamula MJ: From T to B and back again: positive feedback in systemic autoimmune disease. Nature Rev Immunol 2001;1:147–153. Gleichmann H, Gleichmann E, Andre-Schwartz J, et al: Chronic allogeneic disease. 3. Genetic requirements for the induction of glomerulonephritis. J Exp Med 1972;135:516–532. Via CS, Sharrow SO, Shearer GM: Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J Immunol 1987;139:1840–1849. Andrews BS, Eisenberg RA, Theofilopoulos AN, et al: Spontaneous murine lupus-like syndromes. Clinical and immunopathological man ifestations inseveral strains. J Exp Med 1978;148: 1198–1215. Eisenberg RA, Tan EM, Dixon FJ: Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med 1978;147:582–587. Elkon KB, Bonfa E, Llovet R, et al.: Association betweenanti-Sm and antiribosomal P proteinautoantibodies in human systemic lupus erythematosus and MRL/lpr mice. J Immunol 1989;143:1549–1554. Satoh M, Langdon JJ, Chou CH, et al.: Characterization of the Su antigen, a macromolecular complex of 100/102 and 200-kDa proteins recognized by autoantibodies in systemic rheumatic diseases. Clin Immunol Immunopathol 1994;73:132–141. Treadwell EL, Cohen P, Williams D, et al.: MRL mice produce anti-Su autoantibody, a specific marker for systemic lupus erythematosus. J Immunol 1993;150: 695–699. Davignon JL, Cohen PL, Eisenberg RA: Rapid T cell receptor modulationaccom panies lack of in vitro mitogenic responsiveness of double negative T cells to anti-CD3 monoclonal antibody in MRL/Mp-lpr mice. J Immunol 1988;141: 1848–1854. Theofilopoulos AN, Eisenberg RA, Bourdon M, et al.: Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes. J Exp Med 1979;149:516–534. Nagata S, Golstein P: The Fas death factor. Science 1995;267: 1449–1456. Nagata S, Suda T: Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995;16:39–43. Izui S, Kelley VE, Masuda K, et al.: Induction of various auto-antibodies by mutant gene lpr in several strains of mice. J Immunol 1984;133:227–233. Roths JB, Murphy ED, Eicher EM: A new mutation, gld, that produces lymphoproli feration and autoimmunity in C3H/HeJ mice. J Exp Med 1984;159:1–20. Theofilopoulos AN, Balderas RS, Gozes Y, et al.: Association of lpr gene with graft-vs.-host disease-like syndrome. J Exp Med 1985; 162:1–18. Sobel ES, Katagiri T, Katagiri K, et al.: An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J Exp Med 1991;173:1441–1449. Sobel ES, Kakkanaiah VN, Schiffenbauer J, et al.: Novel immuno-regulatory B cell pathways revealed by lpr-+mixed chimeras. J Immunol 1998;160:1497–1503. Weintraub JP, Godfrey V, Wolthusen PA, et al.: Immunological and pathological consequences of mutations in both Fas and Fas ligand. Cell Immunol 1998;186: 8–17. Maldonado MA, Luo HY, Eisenberg RA: LPR B cells still show an intrinsic defect essential for autoantibody production in the absence of FasL overex pression. Arthritis & Rheumatism 2001;44: S287. Kakkanaiah VN, Sobel ES, MacDonald GC, et al.: B cell genotype determines the fine specificity of autoantibody in lpr mice. J Immunol 1997;159:1027–1035. Katagiri T, Cohen PL, Eisenberg RA: The lpr gene causes an intrinsic T cell abnormality that is required for hyperproliferation. J Exp Med 1988;167:741–751. Sobel ES, Cohen PL, Eisenberg RA: lpr T cells are necessary for autoantibody production in lpr mice. J Immunol 1993;150: 4160–4167. Fossati L, Sobel ES, Iwamoto M, et al.: The Yaa gene-mediated acceleration of murine lupus: Yaa-T cells from non-autoimmune mice collaborate with Yaa+B cells to produce lupus autoantibodies in vivo. Eur J Immunol 1995;25: 3412–3417. Sobel ES, Kakkanaiah VN, Cohen PL, et al.: Correction of gladautoimmunity by co-infusion of normal bone marrow suggests that gldisa mutation of the Fas ligand gene. International Immunology 1993;5: 1275–1278. MacDonald GC, Kakkanaiah VN, Sobel ES, et al.: In vivo depletion of Thy-1-positive cells originating from normal bone marrow abrogates the suppression of gld disease in normal-gld mixed bone marrow chimeras. J Immunol 1995;154:444–449. Maldonado MA, MacDonald GC, Kakkanaih VN, et al.: Differential control of autoantibodies and lymphoproliferation by Fas ligand expression on CD4+ and CD8+ T cells in vivo. J Immuno 1999; 163:3138–3142. Katagiri T, Azuma S, Toyoda Y, et al.: Tetraparental mice reveal complex cellular interactions of the mutant, autoimmunity-inducing lpr gene. J Immunol 1992;148: 430–438. Kakkanaiah VN, MacDonald GC, Cohen PL, et al.: Suppression and reversal of gld disease by parabiosis with normal mice. Clin Immunol Immunopathol 1996;78: 6–13. Reap EA, Felix NJ, Wolthusen PA, et al.: bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy. J Immunol 1995;155:5455–5462. Herron LR, Eisenberg RA, Roper E, et al.: Selection of the T cell receptor reportoire in Lpr mice. J Immunol 1993;151:3450–3459. Maldonado MA, Eisenberg RA, Roper E, et al.: Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I. J Exp Med 1995; 181:641–648. Israel EJ, Wilsker DF, Hayes KC, et al.: Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn. Immunology 1996;89:573–578. Sobel ES, Kakkanaiah VN, Kakkanaiah M, et al.: Co-infusion of normal bone marrow partially corrects the gld T-cell defect. Evidence for an intrinsic and extrinsic role for Fas ligand. J Immunol 1995;154:459–464. Dhein J, Walczak H, Baumler C, et al.: Autocrine T-cellsuicide mediated by APO-1/(Fas/CD95). Nature 1995;373:438–441. Eisenberg RA, Craven SY, Warren RW, et al.: Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J Clin Invest 1987;80:691–697. Eisenberg RA, Craven SY, Fisher CL, et al.: The genetics of autoantibody production in MRL/lpr lupus mice. Clin Exp Rheumatol 1989;7:S35-S40. Happern MD, Craven SY, Cohen PL, et al.: Regulation of anti-Sm autoantibodies by the immunoglobulin heavy chain locus. J Immunol 1993;151:7268–7272. Maldonado MA, Kakkanaiah V, MaCdonald GC, et al.: The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J Immunol 1999;162:6322–6330. Robinson DR, Prickett JD, Polisson R, et al.: The protective effect of dietary fish oil on murine lupus. Prostaglandins 1985;30:51–75. Bernard NF, Eisenberg RA, Cohen PL: Response of MRL/Mp-+/+ micetomouse Sm: non-H-2-linked genesdetermine T cell recognition. J Immunol 1985;134:1422–1425. Bernard NF, Eisenberg RA, Cohen PL: H-2-linked 1r gene control of T cell encognition of the Sm nuclear autoantigen and the aberrant response of autoimmune MRL/Mp-+/+ mice. J Immunol 1985; 134:3812–3818. Sobel ES, Kakkanaiah VN, Kakkanaiah M, et al.: T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. J Immunol 1994; 152:6011–6016. Freed JH, Marrs A, VanderWall J, et al.: MHC class II-boundself peptides from autoimmune MRL/lpr mice reveal potential T cell epitopes for autoantibody production in murine systemic lupus erythematosus J Immunol 2000;164; 4697–4705. Eisenberg RA, Pisetsky DS, Craven SY, et al.: Regulation of the anti-Sm autoantibody response in systemic lupus erythematosus mice by monoclonal anti-Sm antibodies. J Clin Invest 1990;85: 86–92. Eisenberg RA, Winfield JB, Cohen PL: Subclass restriction of anti-Sm antibodies in MRL mice. J Immunol 1982;129:2146–2149. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, et al.: The role of clonal selection and somatic mutation in autoimmunity. Nature 1987;328:805–811. Shlomchik M, Nemazee D, van Snick J, et al.: Variable region sequences of murine IgM anti-IgG monoclonal autoanti bodies (rheu-matoid factors). II. Comparison of hydridomas derived by lipopoly-saccharide stimulation and secondary protein immunization. J Exp Med 1987;165:970–987. Shlomchik MJ, Aucoin AH, Pisetsky DS, et al.: Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc Natl Acad Sci USA 1987;84:9150–9154. Eisenberg RA, Theofilopoulos AN, Dixon FJ: Use of bovine conglutinin for the assay of immune complexes. J Immunol 1977;118: 1428–1434. Dixon FJ, Andrews BS, Eisenberg RA, et al.: Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice. Arthrit Rheum 1978;21:S64-S67. Bloom DD, Davignon JL, Retter MW, et al.: V region gene analysis of anti-Sm hybridomas from MRL/Mp-Ipf/Iprmice. J Immunol 1993; 150:1591–1610. Bloom DD, Davignon JL, Cohen PL, et al.: Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-Ipf/Iprimice. J Immunol 1993; 150:1579–1590. Retter MW, Cohen PL, Eisenberg RA, et al.: Both Sm and DNA are selecting antigens in the anti-Sm B cell response in autoimmune MRL/Ipr mice. J Immunol 1996; 156:1296–1306. Eisenberg RA, Sobel ES, Reap EA, et al.: The role of B cell abnormalities in the systemic autoimmune syndromes of Ipr and gld mice. Sem Immunol 1994;6: 49–54. Reap EA, Sobel ES, Cohen PL, et al.: Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice. Clin Immunol Immunopathol 1996;78:21–29. Reap EA, et al.: Conventional B cells, not B-1 cells, are responsible for producing autoa antibodies in lpr mice. J Exp Med 1993;177: 69–78. Bell CG: Ly-1 CD5 B1 cells in normal and in autoimmune pronemice. Biochem Soc Trans 1993;21: 288S. Grillo-Lopez AJ: Rituximab: an insider's historical perspective. Semin Oncol 2000;27:9–16. Treon SP, Anderson KC: The use of rituximab in the treatment of malignant and nonmalignant plasmacell disorders. Semin Oncol 2000;27:79–85. Tedder TF, Klejman G, Disteche CM, et al.: Cloning of a complementary DNA encoding a new mouse B lymphocyte differentiation antigen, homologous to the human B1 (CD20) antigen, and localization of the gene to chromosome 19. J Immunol 1988;141:4388–4394. O'Keefe TL, et al.: Mice carrying a CD 20 gene disruption. Immunogenetics 1998;48:125–132. Sherer Y, Shoenfeld Y: Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 1998;22: 873–881. Aractingi S, et al.: Microchimerism in human diseases. Immunol Today 2000;21:116–118. Nelson JL: Microchimerism: implications for autoimmue disease. Lupus 1999;8:370–374. van der Veen FM, Rolink AG, Gleichmann E: Autoimmune disease strongly resem bling systemic lupus erythematosus (SLE) in Fl mice undergong graft-versus-host reaction (GVHR). Adv Ex Med Biol 1982;149:669–677. van Rappard-Van der Veen FM, Kiesel U, Poels L, et al.: Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease. J Immunol 1984;132: 1814–1820. van Rappard-van der Veen FM, Kong YM, Rose NR, et al.: Injection of mouse thyroglobulinand/or adult thymectomy do not brea tolerance to thyroglobulin during the lupus like graft versus host disease in mice. Clin Exp Immunol 1984;55:525–534. Morris SC, Cheek RL, Cohen PL, et al.: Allotype-specific immunoregulation of autoantibody production by host B cells in chronic graft-versus host disease. J Immunol 1990; 144:916–922. Reap EA, et al.: Conventional B cells, not B1 cells, are the source of autoantibodies in chronic graft-versus-host disease. J Immunol 1993; 151:7316–7323. Morris SC, Cheek RL, Cohen PL, et al.: Autoantibodies in chronic graft versus host result from cognate T-B interactions. J Exp Med 1990;171:503–517. Eisenberg RA, Cohen PL: Class II major histocompatibility antigens and the etiology of systemic lupus erythematosus. Clin Immunol Immunopathol 1983;29:1–6. Laufer TM, Fan L, Glimcher LH: Self-reactive T cells selected on thyrmic cortical epithelium are polyclonal and are pathogenic in vivo. J Immunol 1999;162: 5078–5084. Bradley DS, Jennette JC, Cohen PL, et al.: Chronic graftversus host disease-associated autoimmune manifestations are independently regulated by different MHC class II loci. J Immunol 1994;152: 1960–1969. Chen F, Maldonado MA, Madaio M, et al.: The role of host (endogenous) T cells in chronic graftversus-host autoimmune disease. J Immunol 1998;161:5880–5885. Feuerstein N, Chen F, Madaio M, et al.: Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins. J Immunol 1999; 163:5287–5297. Morris SC, Cohen PL, Eisenberg RA: Experimental induction of systemic lupus erythematosus by recognition of foreign Ia. Clin Immunol Immunopathol 1990;57: 263–273. Klinman DM, Eisenberg RA, Steinberg AD: Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice. J Immunol 1990; 144:506–511. Sekiguchi DR, Jainandunsing SM, Fields ML, et al.: Chronic graftversus-host in Ig knockin transgenic mice abrogates B cell tolerance in anti-double-stranded DNA B cells. J Immunol 2002;168: 4142–4153. Goodnow CC, Glyme R, Mack D, et al.: Glimpses into the balance between immunity and self-tolerance. Ciba Found Symp 1997; 204:190–202. Cornall RJ, Goodnow CC: B cell antigen rece ptor signalling in the balance of to lerance and immunity. Novartis Found Symp 1998;215: 21–30. Goodnow CC, Glynne R, Marck D, et al.: Mechanisms of self-tolerance and autoimmunity: from whole-animal phenotypes to molecular pathways. Cold Spring Harb Symp Quant Biol 1999;64:313–322. Prak EL, Weigert M: Light chain replacement: a new model forantion-body gene rearrangement. J Exp Med 1995;182:541–548. Chen C, Nagy Z, Radic MZ, et al.: The site and stage of anti-DNA B-cell deletion. Nature 1995;373: 252–255. Chen C, Prak EL, Weigert M: Editing disease-associated auto-antibodies. Immunity 1997;6: 97–105. Ibrahim SM, Weigert M, Basu C, et al.: Light chain contribution to specificity in anti-DNA antibodies. J Immunol 1995;155: 3223–3233. Mandik-Nayak L, Bui A, Noorchashm H, et al.: Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med 1997; 186:1257–1267. Noorchashm H, Bui A, Li HL, et al.: Characterization of anergic anti-DNA B cells: B cell anergy is a T cell-independent and potentially reversible process. Int Immunol 1999;11:765–776. Hegde P, Qi R, Abernathy K, et al.: Aconcise guide to cDNA microarray analysis. Biotechniques 2000; 29:548–556. Fahrer AM, Bazan JF, Papathanasiou P, et al.: A genomic view of immunology. Nature 2001;409:836–838.